Propofol and postoperative infections

Area of Science:

• Anesthesiology
• Infectious Disease
• Pharmaceutical Science

Background:

• Propofol's package insert emphasizes strict aseptic technique to prevent infections.
• A reformulated propofol in the US contains disodium edetate as a microbial growth retardant.
• This new formulation is not classified as an antimicrobially preserved product under USP standards.

Purpose of the Study:

• To evaluate the impact of the reformulated propofol on the risk of postoperative infections.
• To highlight the continued importance of aseptic technique in propofol handling.
• To underscore propofol as a potential risk factor for postoperative infections.

Main Methods:

• Review of package insert recommendations for propofol preparation and handling.
• Analysis of microbiologic and clinical evidence regarding propofol and infection risk.
• Examination of USP standards for antimicrobially preserved products.

Main Results:

• The effect of the reformulated propofol on postoperative infection risk is currently unknown.
• Strict aseptic technique remains essential despite the new formulation.
• Specific time limits for propofol use after opening are recommended (6 hours for transferred solutions, 12 hours for direct administration from original container in ICU).

Conclusions:

• Propofol use is identified as an additional risk factor for postoperative infections.
• Hospital personnel require education on and adherence to manufacturer guidelines for propofol handling.
• Preventing outbreaks of infection requires rigorous aseptic practices during propofol preparation and administration.